Cardiovascular system recommendations
On this page you will find our recommendations sorted by BNF chapter.
Appraisal Reports are available to stakeholders on request.
Where a decision is >24 months old; these are highlighted in red. If you are a clinician working within the NTAG region and would like to prioritise an old decision for re-review please contact the professional secretary on nuth.nyrdtc.rxsupp@nhs.net
| Title | Documents | Decision | Date | |
|---|---|---|---|---|
| Left atrial appendage occlusion devices for stroke prevention in patients with non-valvular atrial fibrillation (NETAG) | Recommendation | Recommended for patients with a proven bleeding risk which contraindicates anticoagulation therapy | 10/07/2012 | |
| Stand-alone minimally invasive bipolar radiofrequency ablation for Atrial Fibrillation (NETAG) | Recommendation | Recommended for atrial fibrillation where catheter ablation is not suitable due to clinical, technical or anatomical reasons | 12/07/2011 | |
|
Updated 09/06/2023 |
North East Guideline For Use Of Sodium Glucose Co transporter 2 Inhibitors (SGLT2i) | NENC regional SGLT2 top tips v1.2 - NTAG approved March 2023 - update June 2023 | Approved by NTAG | 21/03/2023 |
|
Updated 26/06/2023 |
NENC Patient Specific Factors to Consider When Choosing a DOAC in NVAF | NENC Decision Aid incl Table to support decison of DOAC - approved June 2022 (extended to June 2024) | Approved by NTAG | 20/06/2023 |
|
Updated 20/09/2022 |
Northern England Evaluation and Lipid Intensification guideline | NEELI edit v2022.2-FINAL-NTAG | Approved by NTAG | 06/09/2022 |
|
New 26/06/2023 |
NENC Shared Care Protocol Dronedarone for patients in adult services | NENC Shared Care Protocol - Dronedarone - June 2023 | Approved by NENC Medicines Subcommittee | 20/06/2023 |